Early Influenza Activity Sparks Global Clinical Surveillance Alert

EARLY influenza activity is rising across northern surveillance regions as seasonal respiratory viral transmission patterns emerge. Global virologic surveillance indicates an initial shift in infection rates, with overall influenza percent positivity increasing across northern hemisphere temperate and subtropical territories while holding below the 10 percent threshold. In contrast, southern hemisphere temperate zones experienced a seasonal decline to approximately 5 percent positivity, whereas tropical corridors maintained steady baseline activity near 15 percent. Influenza A viruses predominated overwhelmingly across reporting laboratories, driving the vast majority of early clinical detections and setting the primary antigenic target for immediate outpatient diagnostic preparation.

Subtype Variations and Differential Diagnosis

Although overall northern positivity remains below classic epidemic thresholds, early influenza activity has accelerated in localized hot spots, with percent positivity surpassing 30 percent in multiple countries across Central America, the Caribbean, Western Asia, Southern Asia, and South-East Asia. Characterization of these early detections reveals substantial geographic divergence in viral subtypes. Influenza A(H1N1)pdm09 served as the predominant circulating subtype across Eastern Africa, Western Asia, South-East Asia, and Oceania, whereas influenza A(H3N2) was dominant throughout Eastern Asia. Central America, the Caribbean, and Southern Asia reported codominance between influenza A and B strains, while influenza B predominated across Tropical and Temperate South America and Western Africa.

Concurrent monitoring of co-circulating pathogens demonstrates that SARS-CoV-2 test positivity remained generally stable and low, although elevated positivity exceeding 10 percent appeared across select nations in South West Europe, Northern Europe, Northern Africa, and Eastern Asia. Respiratory syncytial virus activity was similarly subdued globally, yet localized elevations above 10 percent developed in Central America, South America, and Southern Asia. Dual surges of both influenza and respiratory syncytial virus in select jurisdictions underscore the critical value of multi-pathogen testing during initial patient evaluations. Transmissibility assessments in northern temperate zones currently classify early influenza activity as below seasonal thresholds or low, establishing essential baseline data. These surveillance insights provide clinicians with actionable evidence to optimize testing protocols, guide empirical antiviral administration, and encourage timely seasonal immunization before community transmission peaks.

Reference

World Health Organization. Global respiratory virus activity: weekly update No 602 (week 2026-43). WHO Surveillance Report. 2026.